This will be a prospective, observational study where all implants will be placed in either the maxilla or mandible and loaded immediately (within 48 hours), early (within 6-8 weeks) or delayed (\> 8 weeks) with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 years.
This study aims to enroll a total of 140 patients (140 implants) who are in need of treatment with dental implants in one or more edentulous areas of the maxilla and/or mandible. Approximately 4 sites will be participating, each one contributing 35 patients to the study dataset. The main objectives of this study will be: 1. The integration success of the dental implant (as measured by mobility) 2. The measured changes in peri-implant crestal bone levels for each implant 3. Confirmation of clinical benefits
Study Type
OBSERVATIONAL
Enrollment
139
This clinical study will evaluate patients being treated with the T3 dental implant to confirm its safety and performance (effect of treatment of edentulism). The patients treated will experience a benefit from treatment of edentulism with the T3 dental implant system. The patients will be followed prospectively from the time of exposure (dental implant placement surgery) to outcome (implant survival at 2 years).
University of Florida
Gainesville, Florida, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Virginia Commonwealth University
Richmond, Virginia, United States
Dr. Daniel Engler-Hamm
München, Germany
Dental implant integration
The integration success measured by lack of mobility
Time frame: 2 years
Crestal Bone Loss
The measured changes in peri-implant crestal bone levels
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.